UNSPSC 51453701: Hycanthone

This classification denotes an antihelminthic agent with the molecular formula C20H24N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BXX5EVN2A, chemically known as 9h-thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-(hydroxymethyl)- but generally known as hycanthone, which bears US NIH Compound Identifier 3634. European Medicines Agency schedules Hycanthone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08057MIG.

UNSPSC 51453701 Hycanthone is a Commodity code that nominally describes a specific pharmaceutical compound, but recent state and local opportunities show little activity directly matching this code's narrow scope. Instead, the opportunities posted under this code reflect broader pharmaceutical procurement by state health agencies, county health departments, and municipal fire departments acquiring naloxone, first aid and medical supplies, and generic multi-source pharmaceuticals through competitive bidding and cooperative purchasing arrangements. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP). The work solicited ranges from emergency-response consumables and OTC products to direct-to-manufacturer prescription fulfillment strategies, reflecting health system modernization and cost-containment initiatives across different jurisdictional levels.

Activity concentrates in Florida, Texas, and Minnesota, with opportunities spanning RFPs, RFIs, ITBs, and cooperative purchasing vehicles. Seminole County issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with delivery by July 26, 2023 to the Seminole County Community Health Building. The City of Tampa released ITB 26P00145 in March 2026 for medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with a one-year initial term and two one-year renewals, structured as a sheltered-market procurement for certified small local business enterprises with a 5 percent bid discount. Minnesota MMCAP issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline, requiring manufacturers to supply through three authorized wholesalers with contracts effective July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, reflecting exploratory procurement strategy rather than an immediate award vehicle.